Objectives: This study was to investigate the effect and mechanism of low-intensity pulsed ultrasound (LIPUS) on the proliferation of human amnion-derived mesenchymal stem cells (hAD-MSCs).
| INTRODUCTION
Mesenchymal stem cells (MSCs) are multipotent stem cells that have self-renewal capacity and ability to reconstitute a tissue. [1] [2] [3] [4] Thus, they are widely used in tissue engineering. 5 Mesenchymal stem cells can be isolated from many tissues, including bone marrow, adipose tissue, amniotic fluid, umbilical cord and amnion. Bone marrow is a traditional source of MSCs. However, the population of MSCs in bone marrow is low (about 0.001%-0.01%) 6 and the procedure to obtain bone marrow MSCs (BM-MSCs) is invasive. Moreover, the number, proliferation ability and differentiation potential of MSCs from bone marrow will decrease as the age of donor increases. [7] [8] [9] Thus, it is necessary to find an alternative source of MSCs.
Human amnion-derived mesenchymal stem cells (hAD-MSCs)
isolated from the amnion of term placenta are reported to have the features of MSCs. [10] [11] [12] Human amnion-derived mesenchymal stem cells are able to differentiate towards three germ layers and express stem cell markers similar to BM-MSCs. 3, [12] [13] [14] The procedure to obtain hAD-MSCs is non-invasive, safe and out of ethical debate. 11, 12 Studies have demonstrated that amnion MSCs do not induce xenogeneic and allogeneic immune responses when they were transplanted into animal models. [15] [16] [17] The above advantages make amnion a potentially useful and non-controversial source of MSCs for transplantation and regenerative medicine. 12 The ultimate goal in tissue engineering is the large-scale fabrication of structures, which relies on a large number of immunoprivi- 3 MHz, pulse repetition rates from 100 Hz to 1 kHZ and duty cycles from 20% to 50%. [27] [28] [29] Low-intensity pulsed ultrasound has been reported to be able to generate biochemical events at cellular level. 27, 30, 31 Mesenchymal stem cells have been claimed to have the ability to sense and respond to physical stimuli. 32, 33 Several preliminary studies have suggested that LIPUS can act on MSCs and promote their proliferation in vitro, [34] [35] [36] while some other studies have reported that LIPUS has no effect on or even inhibits the proliferation of stem cells.
37-39
It has been reported that p44/p42 extracellular signal-regulated kinases (ERK1/2) signalling pathway can be activated by various mechanical stimuli, 40 and they are crucial signalling molecules in LIPUS-induced cellular responses. 41, 42 Upon stimulation, ERK1/2 is phosphorylated and activated by mitogen-activated protein kinase kinases 1/2 (MEK1/2), and then translocated into nuclei and modulates downstream genes relevant to cell proliferation and differentiation. Phosphatidylinositol-3-kinase (PI3K)-Akt signalling pathway is another important pathway involved in regulation of cell proliferation. Phosphorylated Akt acts on the downstream target factors and plays a role in cell cycle regulation and cell growth. It has been reported that PI3K-Akt pathway serves an important role in the proliferation of MSCs. 25, 43, 44 However, whether ERK1/2 and PI3K/Akt signalling pathways are involved in the effect of LIPUS on proliferation of hAD-MSCs are unknown.
In this study, the LIPUS effect on the proliferation of hAD-MSCs was determined, and the roles of ERK1/2 and PI3K/Akt signalling pathways were studied. These findings may provide evidence for the application of LIPUS in promoting the viability and proliferation of stem cells and may benefit the use of stem cells in tissue engineering and clinical treatment. 
| MATERIALS AND METHODS

| Reagents
| Isolation and culture of hAD-MSCs
Human amnion-derived mesenchymal stem cells were isolated from term amnion according to the protocol described by Fang et al. 45 Term placentas from healthy donors (n = 30) were collected from patients who received caesarean sections at the Second Affiliated Hospital of Chongqing Medical University, China. Written informed consent was obtained from all donors before collection, and this study was approved by the Ethics Committee of Chongqing Medical University.
The amnion was carefully separated from placenta, washed and then cut into approximate 1 × 1 cm 2 fragments. The amnion fragments were then incubated in D-Hank's buffer containing 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) at 37°C to digest for 40 min.
The mixture was filtered through a 300 mesh sieve, and the residues were collected and repeated with the above process once. The residues were further digested with 0.75 mg/mL of collagenase II and 0.075 mg/ mL of DNase I at 37°C for 1. 
| Optimization of LIPUS treatment protocol and dosage
The LIPUS exposure device (Chongqing Haifu Medical Technology Co.
Ltd., Chongqing, China) consists of an array of six transducers (34.8 mm in diameter), which is specifically designed for a six-well culture plate.
The ultrasound intensity near the transducer surface has been proven to be constant throughout the cross-sectional area. 46 The 6-or 96-well plates were placed on the transducers with a thin layer of ultrasound gel between them. The parameters of LIPUS device was set at a frequency of 0.25 MHz with a 200 μs burst width sine wave, a duty cycle of 20% and a pulse repetition frequency of 1 kHz. Cells in LIPUS groups were exposed to LIPUS, while those in control group received sham irradiation (ultrasound generator was not switched on). The optimal spatial-average temporal-average intensity (I SATA ) and exposure time (ET) were determined by CCK-8 assay and cell cycle analysis.
| CCK-8 assay
Human amnion-derived mesenchymal stem cells were seeded in 96- 
| Flow cytometry
To identify the isolated hAD-MSCs, the expression of MSCs surface markers on hAD-MSCs was detected by flow cytometry. Cells 
| In Vitro Differentiation
Human amnion-derived mesenchymal stem cells were seeded at a density of 1 × 10 5 /cm 2 in a six-well plate for the following differentiation studies.
| Osteogenesis
When cell confluency reached 50%-70%, the culture medium was replaced with ODM and cultured for 21 days. The ODM medium was changed every 3 days. After 21 days, the cells were fixed in PBS containing 4% paraformaldehyde for 30 min, washed three times with PBS, and stained with 1% Alizarin Red S (pH = 4.2) for 5 minutes.
| Adipogenesis
When cell confluency was 100%, the medium was replaced with ADM and cultured for 21 days. The ODM medium was changed every 2-3 days. After 21 days, the cells were fixed, washed and stained with
Oil Red O for 60 min.
| Chondrogenesis
As the cells were cultured to 70%-80% confluency, the medium was replaced with CDM and cultured for 21 days. The medium was changed every 2-3 days. After 21 days, the cells were fixed, washed and stained with Alician blue for 30 minutes.
After staining, images were taken by an inverted microscope (Olympus Corporation).
| Western blot
For cyclin detection, hAD-MSCs were treated as described in cell cycle assay. For other detection, hAD-MSCs were pre-treated with U0126
(10 μmol/L) (specific inhibitors of ERK1/2 pathway) or LY294002
(50 μmol/L) (specific inhibitors of PI3K-Akt pathway) for 1 hour, followed 
| EdU assay
Cells were treated as described in Western blot analysis. Then, the 
| Statistical analysis
For all assays, at least three independent experiments were performed. All data were analysed with statistical software SPSS 22.0 (IBM, NY, USA). Quantitative data were expressed as mean ± standard deviation (SD). Independent samples t test and one-way analysis of variance (ANOVA) were respectively used for two-group and multiple-group comparisons. Statistical significance was set at P < .05.
| RESULTS
| Identification of hAD-MSCs
About an average of 3.08 ± 1.36 × 10 The hAD-MSCs cultured in CDM showed cartilage-specific proteoglycans ( Figure 3G ), which were stained by Alcian blue ( Figure 3H,I ).
These results indicate that hAD-MSCs may have great potentials to differentiate into multiple types of cells.
| Determination of the optimal dose and exposure time of LIPUS
To determine the optimal dose and exposure time of LIPUS on hADMSCs proliferation, we first performed CCK-8 assay. Generally, the mean OD values of the LIPUS groups were higher than those of the control group (Table 1) . The cell viability increased significantly in the LIPUS groups irradiated for 10 or 20 min (P < .05) as the LIPUS intensity increased. However, there was no significant difference between the obviously increased groups (P > .05). At 30 min ET, cells treated with 30 mW/cm 2 LIPUS had a significantly higher viability than that of the control group (P < .05), while those treated with higher intensities were not significantly changed (P > .05). The LIPUS groups, of which the mean OD values were significantly higher than those of the control groups (P < .05), were selected for the cell cycle assay by flow cytometry. Then, cell cycle distribution was analysed. As shown in Figure 4A and Table 2 , the distribution of cells in G0/G1 phase after LIPUS treatment significantly reduced (P < .05) compared to the control group, while the cells in S and G2/M phases increased significantly (P < .05).
The percentages of cells in S and G2/M phases reached a maximum
number at an intensity of 30 mW/cm 2 and ET of 30 min. These results demonstrate that LIPUS can induce cells to enter S and G2/M phases from G0/G1 phase, which was considered as a sign of the proliferation of hAD-MSCs. Low-intensity pulsed ultrasound at I SATA = 30mW/cm 2 and ET = 30 min was determined to be the optimal condition and was used in the following experiments.
To confirm the results of cell cycle assay, cyclin D1, cyclin E1, cyclin A2 and cyclin B1, which are necessary for cell cycle control, were detected by Western blot. It was found that LIPUS significantly upregulated cyclin D1, cyclin E1, cyclin A2 and cyclin B1 expression (P < .05, Figure 4B ,C). These results further demonstrate that LIPUS may activate the transcription of cyclins and thus promote cell cycle progression.
| Effects of LIPUS on the growth of hAD-MSCs
To further define the effects of LIPUS on cell proliferation, EdU incorporation assay, which is a more sensitive and specific method, 47,48 was performed. The hAD-MSCs proliferation ratio of the LIPUS group was significantly higher than that of the control group (P < .01, Figure 5A ,B).
Subsequently, the growth curves of hAD-MSCs in the LIPUS group and control group were investigated by CCK-8 assay, and the results showed that LIPUS significantly promoted the proliferation of hADMSCs ( Figure 5C , P < .05 and P < .01). These results further demonstrate that LIPUS can promote the proliferation of hAD-MSCs in vitro.
| Activation of ERK1/2 and Akt in LIPUS-induced hAD-MSCs
Extracellular signal-regulated kinases (ERK1/2) and PI3K-Akt signalling pathways have been reported to play an important role in cell proliferation. 25, 49 Western blot was performed to monitor the key proteins of the ERK1/2 and PI3K-Akt signalling pathways. It was found that significant phosphorylation of ERK1/2 and Akt was rapidly induced by LIPUS ( Figure 6A , P < .05 and P < . Cell proliferation was assessed by CCK-8 and EdU assays. Cell viability of the LIPUS-treated group was significantly higher than that of the LIPUS group pre-treated with U0126 or LY294002 (LIPUS + inhibitor groups) and the control group at 24 hours (P < .01, Figure 7A ,B). The EdU incorporation assay also showed that the hAD-MSCs proliferation ratio increased significantly by LIPUS treatment compared to the control group and this increase was blocked by the pre-treatment with U0126 or LY294002 (P < .01, Figure 7C-F ).
These results demonstrate that the ERK1/2 and PI3K-Akt signalling pathways are involved in the promotive effect of LIPUS on hAD-MSCs proliferation.
| DISCUSSION
In this study, hAD-MSCs were successfully isolated from human term and CDK4 and inactivating the inhibitors of CDKs, including p21cip1, p27kip1 and forkhead transcription factor. 53 As the cell cycle enters S and G2/M phases from G0/G1 gradually, cell proliferation is promoted finally.
In this study, the roles of ERK1/2 and Akt signalling pathways in LIPUS-induced cell proliferation were further investigated. We found that the amounts of p-ERK1/2 and p-Akt increased significantly after LIPUS treatment. In addition, when the LIPUS-treated hAD-MSCs were, respectively, pre-treated with inhibitors, U0126 and LY294002, the amounts of p-ERK1/2 and p-Akt significantly decreased, thus inhibiting the LIPUS-induced hAD-MSCs proliferation. Therefore, it is highly possible that LIPUS promotes the hAD-MSCs proliferation via the phosphorylation and activation of ERK1/2 and Akt.
However, the exact mechanism by which LIPUS activates the ERK1/2 and Akt signalling pathways remains unclear. It has been reported that LIPUS can promote expression and release of various and Akt. Thus, we speculate that two possible mechanisms might be responsible for the LIPUS-activated ERK1/2 and Akt signalling pathways in this study. One is that LIPUS may induce the expression and release of growth factors that cause the activation of ERK1/2 and Akt signalling pathway. 27, 54, 58 The other is that the mechanical stress produced by LIPUS can directly induce phosphorylation of ERK and Akt through sensing receptors for the mechanical stress 42,59-62 and upstream signalling molecules. 40, 42 However, this speculation needs to be further studied.
In conclusion, LIPUS can promote the proliferation of hAD-MSCs, and the activation of ERK1/2 and PI3K-Akt signalling pathways may be involved in this process. The findings of this study provide important experimental evidence for the application of LIPUS in promoting the proliferation of MSCs.
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